Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.
MMSI - Merit Medical Systems, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$94.20
DETAILS
HIGH:
$107.00
LOW:
$78.00
MEDIAN:
$96.00
CONSENSUS:
$94.20
UPSIDE:
32.19%
Stock News
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
SOUTH JORDAN, Utah, July 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2026, after the close of the stock market on Thursday, July 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, July 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
MMSI or WST: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Merit Medical (MMSI) and West Pharmaceutical Services (WST). But which of these two stocks offers value investors a better bang for their buck right now?
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is the Options Market Predicting a Spike in Merit Medical Systems Stock?
Investors need to pay close attention to MMSI stock based on the movements in the options market lately.
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
MMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.
Merit Medical Systems, Inc. (MMSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Merit Medical Systems, Inc. (MMSI) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Here's Why Merit Medical (MMSI) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merit Medical Systems Inc (MMSI) Shares Fall 3.1% -- What GF Score of 79 Tells Investors
On May 27, 2026, Merit Medical Systems Inc (MMSI) shares fell 3.1% to a current price of $62.52. This decline is part of a broader trend, with the stock down 29
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. Ward to the company's Board of Directors at Merit's annual meeting of shareholders.
A Merit Medical Systems Director Sold 5,000 Company Shares. What Does That Mean for Investors?
This medical device innovator, serving hospitals worldwide, reported a notable insider sale amid a year of share price declines.
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Merit Medical to Participate in the Bank of America Healthcare Conference
SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will participate in the Bank of America 2026 Health Care Conference, to be held in Las Vegas, Nevada, May 12-14, 2026.
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merit Medical Systems: Creating More Growth Engines (Rating Upgrade)
Merit Medical Systems trades at 17-18x earnings with solid fundamentals, moderate leverage, and reasonable valuation, supporting an upbeat outlook. Q1 organic growth was on the lower end, but full-year guidance was maintained and even slightly raised for sales, reflecting recent M&A contributions. Growth engines include the View Point Medical acquisition and WRAPSODY, both expected to accelerate revenue and margin expansion into 2026.
Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up
MMSI tops Q1 estimates with 9% EPS growth and 7% revenue rise, while lifting its 2026 sales outlook amid steady segment and geographic gains.
Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript
Merit Medical Systems, Inc. (MMSI) Q1 2026 Earnings Call Transcript
Price Targets
Merit Medical price target lowered to $83 from $92 at Baird
$83.00
(was $64.61)
David Rescott
·
Robert W. Baird
Merit Medical price target lowered to $107 from $109 at Barrington
$107.00
(was $70.93)
Michael Petusky
·
Compass Point
Merit Medical price target lowered to $96 from $106 at Piper Sandler
$96.00
(was $70.10)
Piper Sandler
Wells Fargo Downgrades Merit Medical Systems, Inc. (MMSI) to Equal Weight
$78.00
(was $79.23)
Larry Biegelsen
·
Wells Fargo
Merit Medical price target lowered to $106 from $113 at Piper Sandler
$106.00
(was $81.59)
Piper Sandler
Merit Medical initiated with a Buy at BTIG
$107.00
(was $79.63)
BTIG
Merit Medical price target raised to $99 from $93 at Canaccord
$99.00
(was $86.85)
Canaccord Genuity
Merit Medical price target raised to $108 from $103 at Baird
$108.00
(was $86.41)
David Rescott
·
Robert W. Baird
Merit Medical price target raised to $106 from $103 at Barrington
$106.00
(was $88.98)
Barrington
Merit Medical price target raised to $103 from $102 at Baird
$103.00
(was $86.16)
David Rescott
·
Robert W. Baird
Merit Medical price target raised to $104 from $103 at Canaccord
$104.00
(was $80.47)
John Young
·
Canaccord Genuity
Merit Medical price target raised to $112 from $108 at Canaccord
$112.00
(was $96.49)
John Young
·
Canaccord Genuity
Merit Medical price target lowered to $103 from $111 at Barrington
$103.00
(was $93.86)
Michael Petusky
·
Barrington
Merit Medical price target lowered to $110 from $111 at Baird
$110.00
(was $94.61)
David Rescott
·
Robert W. Baird
Merit Medical price target lowered to $106 from $117 at Wells Fargo
$106.00
(was $94.61)
Larry Biegelsen
·
Wells Fargo
Merit Medical Systems, Inc. (MMSI) PT Raised to $107 at Baird
$107.00
(was $95.52)
David Rescott
·
Robert W. Baird
Needham Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)
$105.00
(was $96.16)
Mike Matson
·
Needham
Merit Medical Systems, Inc. (MMSI) PT Raised to $103 at Wells Fargo
$103.00
(was $96.16)
Larry Biegelsen
·
Wells Fargo
Merit Medical Systems, Inc. (MMSI) PT Raised to $103 at BofA Securities
$103.00
(was $96.16)
Craig Bijou
·
Bank of America Securities
Merit Medical price target raised to $110 from $100 at Piper Sandler
$110.00
(was $96.58)
Jason Bednar
·
Piper Sandler